PL344534A1 - Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment - Google Patents

Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment

Info

Publication number
PL344534A1
PL344534A1 PL98344534A PL34453498A PL344534A1 PL 344534 A1 PL344534 A1 PL 344534A1 PL 98344534 A PL98344534 A PL 98344534A PL 34453498 A PL34453498 A PL 34453498A PL 344534 A1 PL344534 A1 PL 344534A1
Authority
PL
Poland
Prior art keywords
diagnosis
tools
recognized
treatment
rheumatoid arthritis
Prior art date
Application number
PL98344534A
Other languages
English (en)
Inventor
Lydie Meheus
Ann Union
Joseph Raymackers
Original Assignee
Innogenetics Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98870078A external-priority patent/EP0949270A1/fr
Application filed by Innogenetics Nv filed Critical Innogenetics Nv
Publication of PL344534A1 publication Critical patent/PL344534A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL98344534A 1997-11-28 1998-11-30 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment PL344534A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97870195 1997-11-28
EP98870078A EP0949270A1 (fr) 1998-04-09 1998-04-09 Peptides synthétiques contenant de la citrulline et reconnus par les sérums de patients souffrant d'arthrite rhumatoide utilisés comme outils de diagnostic et de traitement
PCT/EP1998/007714 WO1999028344A2 (fr) 1997-11-28 1998-11-30 Peptides synthetiques contenant une citrulline reconnue par les serums de malades atteints de polyarthrite rhumatoide comme des outils de diagnostic et de traitement

Publications (1)

Publication Number Publication Date
PL344534A1 true PL344534A1 (en) 2001-11-05

Family

ID=26148315

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98344534A PL344534A1 (en) 1997-11-28 1998-11-30 Synthetic peptides containing citrulline recognized by rheumatoid arthritis sera as tools for diagnosis and treatment

Country Status (8)

Country Link
EP (1) EP1034186A2 (fr)
JP (1) JP2002512939A (fr)
AU (1) AU2155899A (fr)
CA (1) CA2309534A1 (fr)
CZ (1) CZ20001963A3 (fr)
HU (1) HUP0004338A2 (fr)
PL (1) PL344534A1 (fr)
WO (1) WO1999028344A2 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7184426B2 (en) 2002-12-12 2007-02-27 Qualcomm, Incorporated Method and apparatus for burst pilot for a time division multiplex system
FR2773078B1 (fr) * 1997-12-30 2000-05-26 Univ Toulouse Utilisation de peptides citrullines derives de la filaggrine pour le traitement de la polyarthrite rhumatoide
DE1240180T1 (de) * 1999-12-21 2003-08-14 Innogenetics N.V., Gent Peptide zur diagnose und behandlung rheumatischer arthritis
FR2826124B1 (fr) 2001-06-13 2004-01-02 Bio Merieux Procede de detection d'auto-anticorps specifiques de la polyarthrite rhumatoide
NL1019540C2 (nl) * 2001-12-11 2003-07-01 Stichting Tech Wetenschapp Werkwijze voor het detecteren van auto-antilichamen van patienten die lijden aan reumatoïde artritis, peptide en assaykit.
CN1809753B (zh) * 2003-07-29 2010-10-20 索尔瓦药物有限公司 通过二维凝胶电泳分析包含生理可接受消化酶混合物的方法
AT413768B (de) * 2003-07-29 2006-05-15 Herkner Kurt Dipl Ing Dr Techn Biochemisches diagnostikum zur erkennung rheumatoider arthritis
WO2005064307A2 (fr) * 2003-12-23 2005-07-14 Roche Diagnostics Gmbh Methode de diagnostic de la polyarthrite rhumatoide, consistant a mesurer la concentration d'anti-ccp et d'interleukine 6
ES2314621T3 (es) 2004-02-27 2009-03-16 F. Hoffmann-La Roche Ag Procedimiento de evaluacion de la artritis reumotoidea, mediante la medicion de anti-ccp y amiloide a serico.
PL2278002T3 (pl) 2005-07-29 2017-12-29 Abbott Laboratories Gmbh Pankreatyna o zmniejszonej zawartości wirusowej
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
GB0525492D0 (en) * 2005-12-15 2006-01-25 Univ Dundee Filaggrin
FR2900657B1 (fr) * 2006-05-03 2009-04-17 Univ Toulouse Identification de modulateurs de l'activation des macrophages, utilisables pour le traitement de la polyarthrite rhumatoide
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
WO2008037420A1 (fr) 2006-09-29 2008-04-03 Roche Diagnostics Gmbh Évaluation du risque de progression de la maladie pour un patient présentant une polyarthrite rhumatoïde
ES2390394T3 (es) 2007-12-03 2012-11-12 Sqi Diagnostics Systems Inc. Péptidos sintéticos inmunorreactivos con los autoanticuerpos de la artritis reumatoide
EP2294086B1 (fr) 2008-06-04 2017-09-13 ModiQuest B.V. Agents anti-inflammatoires
CA2757444A1 (fr) * 2009-03-30 2010-10-14 Prometheus Laboratories Inc. Peptides citrullines pour diagnostiquer et pronostiquer une polyarthrite rhumatoide
EP2325195A1 (fr) 2009-11-23 2011-05-25 Toscana Biomarkers S.r.l. Peptides à citrulline et utilisations associées
EP2336769A1 (fr) 2009-12-18 2011-06-22 F. Hoffmann-La Roche AG Test pour différencier les troubles rhumatismaux des troubles non rhumatismaux
EP2402368A1 (fr) 2010-07-02 2012-01-04 Toscana Biomarkers S.r.l. Peptides de citrulline histone et utilisations associées
EP2527841A1 (fr) 2011-05-25 2012-11-28 Toscana Biomarkers S.r.l. Procédés pour le diagnostic de l'arthrite rhumatoïde
WO2012163768A1 (fr) * 2011-05-27 2012-12-06 Nordic Bioscience A/S Détection de peptides diagnostiques
US9322822B2 (en) * 2011-08-12 2016-04-26 Hiroshima University Method for detecting asbestos
BR112014014767A2 (pt) 2011-12-16 2017-06-13 Olema Pharmaceuticals Inc novos compostos de benzopirano, composições e usos dos mesmos
WO2014141244A1 (fr) * 2013-03-12 2014-09-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Peptides destinés au traitement de maladies autoimmunes
WO2015010791A2 (fr) 2013-07-24 2015-01-29 Klareskog, Lars Nouveaux anticorps pour le diagnostic et le traitement de la polyarthrite rhumatoïde
KR101634958B1 (ko) * 2014-06-13 2016-06-30 한국생명공학연구원 필라그린 유전자 돌연변이 검출용 프로브, 키트 및 방법
EP3056903A1 (fr) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Procédé d'évaluation de l'arthrite rhumatoïde par la mesure de l'anti-CCP et de l'anti-Casp8
WO2016128348A1 (fr) 2015-02-13 2016-08-18 F. Hoffmann-La Roche Ag Procédé d'évaluation de la polyarthrite rhumatoïde par mesure des anti-ccp et anti-pik3cd
EP3056904A1 (fr) 2015-02-13 2016-08-17 F. Hoffmann-La Roche AG Procédé pour l'évaluation de l'arthrite rhumatoïde par la mesure de l'anti-CCP et de l'anti-MCM3
CN111007262A (zh) * 2019-12-25 2020-04-14 漳州卫生职业学院 一种用于辅助诊断ra的试剂盒及检测方法
CN122063281B (zh) * 2026-04-20 2026-06-30 苏州大学 一种用于诊断类风湿性关节炎的生物标志物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5660994A (en) * 1986-11-10 1997-08-26 Progen Biotechnik Gmbh Method of detecting tissue-specific, insoluble cytoskeletal proteins
DE511116T1 (de) * 1991-04-26 1993-04-29 Clonatec S.A., Paris Antigene, die von polyarthritis rheumatoide antikoerpern erkannt werden, ihre herstellung und ihre anwendungen.
FR2752842B1 (fr) * 1996-08-30 1998-11-06 Biomerieux Sa Antigenes derives des filaggrines et leur utilisation pour le diagnostic de la polyarthrite rhumatoide
NL1004539C2 (nl) * 1996-11-15 1998-05-20 Stichting Tech Wetenschapp Peptide afgeleid van een door auto-antilichamen van patiënten met reumatoïde artritis herkend antigeen, antilichaam daartegen en werkwijze voor het detecteren van auto-immuunantilichamen.

Also Published As

Publication number Publication date
CZ20001963A3 (cs) 2002-04-17
WO1999028344A2 (fr) 1999-06-10
JP2002512939A (ja) 2002-05-08
AU2155899A (en) 1999-06-16
EP1034186A2 (fr) 2000-09-13
CA2309534A1 (fr) 1999-06-10
HUP0004338A2 (hu) 2001-02-28
WO1999028344A3 (fr) 1999-08-12

Similar Documents

Publication Publication Date Title
EG21902A (en) Containers
SG91246A1 (en) Toner bottle
EP0730678A4 (fr) Agitateur a ultrasons
GB9309142D0 (en) Laparoscopic instrument
GB9506962D0 (en) Containers
GB9412166D0 (en) Retargetting antibodies
GB9521260D0 (en) Sample container
GB9312578D0 (en) Determining gas concentration
HUP0103605A3 (en) Resilient containers for hyperpolarized gases
GB2301055B (en) Containers
GB9314802D0 (en) Modified proteins
EP0731164A4 (fr) PHOSPHOLIPASE C-alpha HUMAINE ET SEQUENCE D'ADN CODANT POUR CET ENZYME
GB9320046D0 (en) Container testing
GB2304329B (en) Containers
AU124488S (en) Toner bottle
GB9608887D0 (en) Tool container
ZA982338B (en) Method for the diagnosis of rheumatoid arthritis
EP0682117A4 (fr) Adn codant l'anhydrase carbonique
GB9311113D0 (en) Probes
GB2305906B (en) Containers
GB9312255D0 (en) Receptacle
KR960005079Y1 (en) Buoy for sea-farming
GB2302948B (en) Analyser for liquids
CA76773S (en) Toner bottle
GB9511037D0 (en) Tool container